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Systems biology: a new term for an old
science
Prior to the outburst of molecular genetics in the latter part of
the past century, studying biological systems in their whole
was commonplace owing to the limited scientiﬁc knowledge
and appropriate molecular tools available. The molecular
understanding of each observable phenotype was uncertain
and based on empirical deductions from complete systems
(Von Bertalanffy, 1950; Kacser and Burns, 1973). Large-scale
molecular biology has led to the routine deciphering of
genome sequences and the subsequent identiﬁcation of gene
products and metabolites. Using these molecular reagents,
thousands of studies have drawn novel molecular mechan-
isms, deﬁned signalling cascades and molecular interactions.
However, despite the ever-increasing ability to catalogue the
players in biological systems, the relationship between overall
behaviour of the biological system and the newly discovered
molecular mechanisms remains often puzzling and elusive.
This is relevant not only to the general understanding of
biology but also to its application in understanding human
disease. The production of a ‘disease’ phenotype is the result
of many interacting components, from ‘simple’ monogenic
diseases through to complex disease with multiple genetic and
environmental factors. If we wish to deﬁne the molecular
targetsappropriatefortherapeuticintervention,developbetter
diagnostics and understand how environmental factors
inﬂuence disease, we must return to the study of complete
biologicalsystems armedwiththeeverexpandingcatalogue of
molecular reagents. Systems biology is a new term for the old
science of studying biological systems holistically, but now
reinforced with high-throughput, increasingly affordable
molecular tests and considerable sophistication in computa-
tional modelling (Kitano, 2002). We will focus here on the
informatics of systems biology and how this rediscovered
discipline is changing the way computers are used in
molecular biology.
Where computational systems biology
meets experimental systems biology
Organized merging of computational systems biology with
experimental systems biology is the most important challenge
facing modern laboratories. We categorize the informatics into
three distinct layers, each of which needs its own expertise
and investment, but fundamentally provide information into
the next one. The layers are (i) close-to-data generation
informatics, (ii) large data sets informatics and (iii) systems
modelling informatics.
Close-to-data generation informatics
Experiments that inherently handle many data points require
their own software and databases speciﬁc to the experimental
system. Most equipment (e.g. microarray platforms, proteo-
mics, automated microscopes, among others) come with their
own computer and software bundled with the instrument. The
standardization of these computational tools is very variable
depending on the maturity of the overall industry and the
investment by both the instrumentation company and early
adopter sites. Any laboratory using such equipment will need
increasing sophistication in computational methods with
personnel who are competent in extracting, moving and
troubleshooting data sets in a computational setting. We
estimate that between 20 and 30% of the salary resource
should be dedicated to close-to-data production informatics.
These include mostly database generation and maintenance
tools such as Laboratory Information Management Systems
(LIMS). Examples of data management system are SBEAMS
(Institute for Systems Biology) or BASE, for microarray
analysis (Saal et al, 2002).
Bioinformatics of large data sets
Modern high-throughput technologies produce large amounts
of data quickly, and their storage and organization require
informatics resources. Databases can be separated into two
overlappingcategories,thatis,experimentaldatabasessuchas
Arrayexpress for microarray data (Parkinson et al, 2005) or
IntAct for protein–protein interactions (Hermjakobet al, 2004)
on the one hand, and knowledge databases on the other hand,
to which the ﬁrst ones can be compared, interpreted and
integrated. Such knowledgebase can consist, among others, of
attributes of proteins mined in-depth from the literature such
as Uniprot (Bairoch et al, 2005), or qualitative molecular
reactions and signalling pathways such as Reactome (Joshi-
Tope et al, 2005). These data sets are most useful when made
public,allowing othergroups to queryandintegrate theirdata.
To do so, there is increasingly sophisticated bioinformatics
software such as Cytoscape (Shannon et al, 2003) and
Bioconductor (Gentleman et al, 2004). Despite the availability
of these data sets and software, we believe that some critical
components in the integration of public data sets with ‘local’
private data are currently underdeveloped. This is part of the
focus of our project, ENFIN, described below.
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One of the most effective ways to investigate the properties
of a given system is to build a computational model of it. The
computational model can then be used to simulate system’s
behaviour and potentially reveal whether experimental results
are consistent or not with the model. A researcher can build
a deeper understanding of the system by iterating between
model design, testing and validation using experimental
challenges. This is particularly true when an emergent
behaviour of the model cannot be easily explained by simple
‘presence/absence’ arguments, such as a meta-stable switch-
like response between two states triggered by a threshold of
an input signal. The development, theory and use of these
computational models represent the third computational area
in systems biology (Figure 1).
Quantitativeand qualitative modelling of biological systems
started with the ones of metabolic processes in cells, which
remain a strength in the ﬁeld. These models can be based on
stoichiometric properties of metabolic pathways (Kacser and
Burns, 1973) or, in the case where more detailed parameters
are available, kinetic modelling as a series of differential
equations (Le Novere et al, 2005; Kowald et al, 2006). These
models become quite sophisticated and there is a growing
endeavour of cataloguing, testing and aggregating them, for
example using Systems Biology Markup Language (SBML)
and databases of models, for example, BioModels Database
(Le Novere et al, 2006) or CellML (Lloyd et al, 2004). Kinetic
modelling is not the only framework aiming at understanding
biological systems. Simpler models based on Boolean logic
gates or simpler analogies with electrical circuits allow more
complex systems with fewer known parameters to be tackled
(Thomas, 1973; Savinell and Palsson, 1992; Sanchez and
Thieffry, 2003). This area of modelling merges progressively
with investigations of large-scale data sets, such as the use of
graphical Bayesian methods, which can learn aspects of the
model from large-scale data sets (Segal et al, 2005).
Although there is considerable sophistication in the
construction and use of these modelling methods in speciﬁc
computational groups, they remain mostly forsaken by
experimentally focused biologists. This is mainly owing to
engineering aspects of how to interact and construct these
models, as well as exchange of knowledge between the
computational groups and experimental groups, both poten-
tial providers of useful modelling frameworks on the one hand
and of useful experimental data for these frameworks on
the other hand. Again we hope to address some of these
shortcomings in ENFIN.
Integration across disciplines
Whereas close-to-data production informatics demands skills
in data reformatting, large data set handling and systems
simulation require analysis bioinformatics and computational
modelling aspects. In practice, these layers may be integrated
via collaborations, a local bioinformatics or systems biology
group, or by people with mixed skills in experimentation and
informatics, including abilities to script, to use sophisticated
statistical tools (R, S, among others) and to understand where
the appropriate biological data sets are.
We have recently started a new project, ENFIN, a European
Network of Excellence to address some of these challenges.
ENFIN (www.enﬁn.org) is mainly a bioinformatics group,
with multiple disciplines distributed across mathematics,
computer sciences and biology. We are mainly focusing our
efforts in the latter two layers of computational systems
biology, namely the integration of public data with local
experimental data and systems biology modelling. In addition
to 15 computational groups, ENFIN comprises ﬁve experi-
mental groups, ranging from investigations into bacterial
metabolism through to mammalian cell signalling. These
experimental groups will be providing both interesting
problems and motivation for the computational groups, which
Figure 1 Schematic representation of the methods currently used to model biological systems of various complexities. Many of the more sophisticated models require
numerous kinetic parameters (or constraints of these parameters) and accurate measurement of the concentration of many of the biochemical species. One could
imaginesuchmodelsbeingeffectivelycombinedwithexperimentsonrelatively‘simple’systemssuchasbacteriaandsingle-celledeukaryotes.Incontrast,itisfarharder
to imagine these detailed models being effective for multicellular eukaryotes, which both have the challenge of different cell types and multiple intracellular
compartments. Qualitative models seem rather more appropriate for metazoan organisms. These include Boolean models and graphical Bayesian models. In both
cases, simpler and noisier data sets can be used to inform or train the models.
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knowledge by applying methods to predict protein function,
reconstruct protein networks and modelling systems; consis-
tent with our view that close-to-laboratory informatics is
crucial for systems biology, each experimental group is
hiring a dedicated bioinformatician. ENFIN’s infrastructure
will be made publicly available and will be designed in
an open manner, using Web services and other networked
technologies.
The project aims at developing and integrating bioinfor-
maticstoolsin acommonplatformtobeused toanalyseahigh
variety of experimental data sets, and to deliver to the user
a panel of predictions and models virtually expanding the
spectrum of a classical interpretation of biological data sets.
Measuring the impact of such a project is often difﬁcult and
we will illustrate ENFIN’s top-level goals using the TGF-beta
pathway as an example. The TGF-beta pathway represents an
interesting challenge as it produces non-trivial differences in
response to various related stimuli, modulated by cellular
context and other factors (Moustakas and Heldin, 2005).
In normal cells, growth factor signals (like those from
TGF-beta1) are interpreted by tightly regulated networks of
signal-transduction proteins controlling the appropriate cellu-
lar response. Cancer cells are often unresponsive to normal
signalling cascades and show very unpredictable behaviours.
The intracellular signalling machinery seems to consist of
mainly two closely related Smad cascades, the TGF-beta and
the BMP cascades. Various factors can inﬂuence the TGF-beta
pathway: regulatory inputs towards Smads or the nucleus,
such as Ras or the oncoproteins Ski and SnoN; signalling
effectors downstream of Smad, such as the protein kinase A;
signalling effectors downstream of the receptor, such as p38 or
MAPK.Whereas theSmadpathway israthersimpleandlinear,
complex crosstalks with other signalling modules that are also
activated by TGF-beta ligands such as the PI3-kinase/Akt, the
Rho GTPase and the MAPK/JNK/p38K pathways occur. The
role of these alternative pathways in the diversity of cellular
responses remains unclear. There is emerging evidence that
acute activation of a single mitogenic oncogene in mammalian
cells not only promotes cell proliferation but simultaneously
turns growth-opposing cellularprogrammeson. Theseinclude
apoptosis and an irreversible growth arrest termed premature
senescence (Kahlem et al, 2004). Finding either genetic or
pharmacologic means to tilt this balance towards cellular
senescence or apoptosis would provide an intriguing oppor-
tunity for clinicians to selectively target oncogene-expressing
cancer cells to destruction.
The use of ENFIN as an integrative platform of public data
with known pathways will provide valuable material for
identifying new potential pathways components. Parameters
such as post-translational modiﬁcations or enzyme:substrate
putative interactions will be investigated (for instance,
producing a ranked list of possible phosphorylation processes
involving a given kinase). The considerable knowledge
collected on the TGF-beta pathway is not yet available in
a computational form; ENFIN will facilitate its description,
allowing other tools to automatically analyse large-scale
experimental data sets. Finally, it is likely that ENFIN will
use a Boolean model of the signalling cascade in the ﬁrst
instance to create a predictive model of the pathway. This
model will probably be deﬁcient in some areas and may
suggest either speciﬁc experiments to resolve particular
aspects or impute speciﬁc missing components for the model
to be stable. These hypotheses will be presented back to the
experimentalists in the ENFIN network, and newexperiments,
leading to a new round of integration, will be developed.
ENFIN does not just aim at understanding TGF-beta
signalling, but instead uses such examples to drive both
speciﬁc method development and an extensive integration
across computational tools. Our goal is to make these
computational approaches accessible to a broader range
of experimentalists, therefore progressively growing the area
of computational systems biology beyond its traditionally
theoretical level, on the one hand, and introducing more ‘wet’
experimentalists to power these ‘dry’ computational tools, on
the other hand.
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